Cancer research grants now open

Research grants will provide support for clearly defined research applications that can demonstrate a translational route forward or a route to follow-on funding.

Research grants can include any relevant biomedical research. For example, research that can help inform future preclinical and clinical studies, biomarker research including diagnostic and predictive biomarkers, and preclinical studies that generate biological data to underpin therapeutic and diagnostic development. Laboratory-based research intended to maximise the value and outcome of a clinical trial is also eligible.

The cancer research grants round are now open for applications. This scheme will support research projects up to £200,000 and for up to 3 years. We anticipate awarding three grants.

The projects should align with the trust’s clinical R&D strategy and to one of the four themes in the NHS Long Term Plan for cancer. Broadly, these are:

1) Prevention awareness and screening;
2) Diagnosis;
3) Treatment;
4) Personalised care.

Project grants will provide support for clearly defined research applications that are innovative and can demonstrate a translational route towards new or improved approaches to prevention, diagnosis, treatment or personalised care.

Projects should aim to address key questions in the cancer field. This can include any relevant basic biological research that can help inform future preclinical and clinical studies, biomarker research including diagnostic and predictive biomarkers, and preclinical studies that generate biological data to underpin therapeutic and diagnostic development. Laboratory-based research projects using samples collected as part of a clinical trial are also eligible.

Applications for research on rare cancers must be able to demonstrate significant potential benefit and/or the applicability or translational potential to other cancers.

Where relevant and given the diverse communities Royal Free London NHS Foundation Trust (RFL) serves, applications must demonstrate consideration of the appropriateness of diversity and inclusion that are relevant to the research aims.

In-line with being an introductory Association of Medical Research Charities member, the funding available will only support directly-incurred costs and not directly-allocated or indirect costs. Eligible costs include staff employed on the grant, research consumables, animal costs and publication fees.

Applications will be externally peer-reviewed and assessed by the Research Review Panel. Applicants will be given the opportunity to respond to the peer review comments. Applications will be assessed against the following criteria:

● Alignment with strategic priorities – NHS Long Term Plan for cancer and RFL clinical R&D strategy
● Importance – the research need
● Research design and methodology – sound methodological approaches
● Feasibility – background and underpinning research demonstrated, realistic objectives delivered within the timescale and budget, risks identified and mitigated
● Scale of impact for patients – potential to deliver the stated outcomes and its significance for patients
● Value for money – reasonable and justifiable costs and matched support identified


Timeline
30 January 2023 Cancer research grant round opens
4 April 2023, 4pm Cancer research grant round closes
Mid-June 2023 Rebuttal by applicants
Mid-September 2023 Notification of outcomes

Ineligible costs

● Training or course fees
● PhD studentship fees
● Maintenance or insurance of equipment
● Indemnity insurance
● Personal licence fees
● Indirect/estates costs


Application process

Download:

Cancer research grant scheme 2023 – guidance for applicants

Application form

The deadline for applications will be 4pm on 4 April 2023. Late applications will not be considered.

Any questions? Contact [email protected] and we’ll be happy to assist.